|
Originally published In Press as doi:10.1074/jbc.M008809200 on October 24, 2000
J. Biol. Chem., Vol. 276, Issue 7, 4634-4639, February 16, 2001
Peroxisome Proliferator-activated Receptor Is Not
Rate-limiting for the Lipoprotein-lowering Action of Fish Oil*
Jean
Dallongeville §¶,
Eric
Baugé ,
Anne
Tailleux **,
Jeffrey M.
Peters ,
Frank J.
Gonzalez§§,
Jean-Charles
Fruchart **, and
Bart
Staels **
From the Département
d'Athérosclérose, § INSERM U-508, and
INSERM U-325, Institut Pasteur de Lille, 59019 Lille, France,
** Faculté de Pharmacie, Université Lille 2, 59000 Lille, France,  Center for Molecular
Toxicology, the Pennsylvania State University, University Park,
Pennsylvania 16802, and the §§ Laboratory of
Molecular Carcinogenesis, NCI, National Institutes of Health,
Bethesda, Maryland 20892
Similar to fibrate hypolipidemic drugs, long
chain polyunsaturated fatty acids contained in fish oil are activators
of peroxisome proliferator-activated receptor (PPAR ). The goal
of this study was to assess the contribution of PPAR in mediating
the effect of fish oil on plasma lipid, lipoprotein, and apolipoprotein
levels. To this end, PPAR -deficient mice and wild-type littermates
were fed isocaloric fish oil or coconut oil diets, the content of which varied reciprocally between 0, 3, 7, and 10% for 1 week. In both wild-type and PPAR -deficient mice, fish oil feeding was associated with a dose-dependent decrease in triglycerides,
cholesterol, and phospholipids associated with lower levels of very low
density lipoprotein (VLDL) triglycerides and high density lipoprotein (HDL) cholesterol. The lowering of triglycerides and VLDL triglycerides was associated with a significant decrease of plasma apoC-III in both
genotypes. Fish oil treatment did not influence hepatic apoC-III
mRNA levels in either genotype indicating that apoC-III is not
under transcriptional control by fish oil. The lowering of HDL
cholesterol observed in both genotypes was associated with reduced
plasma apoA-II without changes in liver apoA-II mRNA levels. In
contrast, plasma apoA-I and liver apoA-I mRNA levels were decreased in wild-type but not in PPAR -deficient mice after fish oil feeding indicating that PPAR contributes to the effect of fish oil on apoA-I
gene expression. In conclusion, PPAR is not rate-limiting for fish
oil to exert its triglyceride- and HDL-lowering action. Furthermore,
PPAR mediates, at least partly, the decrease of apoA-I after fish
oil treatment, whereas apoC-III and apoA-II levels are affected in a
PPAR -independent manner. Altogether, these results show major
molecular differences in action between fibrates and fish oil providing
a molecular rationale for combination treatment with these compounds.
*
This study was supported by INSERM and the Pasteur Institute
of Lille.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dépt.
d'Athérosclérose, Institut Pasteur de Lille, 1 Rue du
Professeur Calmette, 59019 Lille Cedex, France. Tel.: 33 320 877 373;
Fax: 33 320 877 360; E-mail:
jean.dallongeville@pasteur-lille.fr.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Vanschoonbeek, K. Wouters, P. E.J. van der Meijden, P. J. van Gorp, M. A.H. Feijge, M. Herfs, L. J. Schurgers, M. H. Hofker, M. P.M. de Maat, and J. W.M. Heemskerk
Anticoagulant Effect of Dietary Fish Oil in Hyperlipidemia: A Study of Hepatic Gene Expression in APOE2 Knock-in Mice
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2008;
28(11):
2023 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C Chan, G. F Watts, M. N Nguyen, and P H. R Barrett
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity
Am. J. Clinical Nutrition,
July 1, 2006;
84(1):
37 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. A. M. Jonkers, A. H. M. Smelt, H. M. G. Princen, F. Kuipers, J. A. Romijn, R. Boverhof, A. A. M. Masclee, and F. Stellaard
Fish Oil Increases Bile Acid Synthesis in Male Patients with Hypertriglyceridemia
J. Nutr.,
April 1, 2006;
136(4):
987 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, T. Y. Nara, and M. T. Nakamura
Peroxisome proliferator-activated receptor {alpha} is required for feedback regulation of highly unsaturated fatty acid synthesis
J. Lipid Res.,
November 1, 2005;
46(11):
2432 - 2440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Wright-Rodgers, M. K. Waldron, K. E. Bigley, G. E. Lees, and J. E. Bauer
Dietary Fatty Acids Alter Plasma Lipids and Lipoprotein Distributions in Dogs during Gestation, Lactation, and the Perinatal Period
J. Nutr.,
September 1, 2005;
135(9):
2230 - 2235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Olivieri, N. Martinelli, M. Sandri, A. Bassi, P. Guarini, E. Trabetti, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, et al.
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and "Insulin-Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction
Clin. Chem.,
February 1, 2005;
51(2):
360 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Davidoff, M. M. Mason, M. B. Davidson, M. W. Carmody, K. K. Hintz, L. E. Wold, D. A. Podolin, and J. Ren
Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments
Am J Physiol Endocrinol Metab,
May 1, 2004;
286(5):
E718 - E724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, O. Ziouzenkova, H. Ni, D. D. Wagner, J. Plutzky, and T. N. Mayadas
Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPARalpha
Blood,
July 30, 2002;
100(4):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vasandani, A. I. Kafrouni, A. Caronna, Y. Bashmakov, M. Gotthardt, J. D. Horton, and D. K. Spady
Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice
J. Lipid Res.,
May 1, 2002;
43(5):
772 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Jump
The Biochemistry of n-3 Polyunsaturated Fatty Acids
J. Biol. Chem.,
March 8, 2002;
277(11):
8755 - 8758.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-M. Chao, C.-Y. Chao, F.-J. Lin, and C.-j. Huang
Oxidized Frying Oil Up-Regulates Hepatic Acyl-CoA Oxidase and Cytochrome P450 4 A1 Genes in Rats and Activates PPAR{alpha}
J. Nutr.,
December 1, 2001;
131(12):
3166 - 3174.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|